These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 20152769)

  • 1. Ki67 in breast cancer: prognostic and predictive potential.
    Yerushalmi R; Woods R; Ravdin PM; Hayes MM; Gelmon KA
    Lancet Oncol; 2010 Feb; 11(2):174-83. PubMed ID: 20152769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer.
    Pathmanathan N; Balleine RL; Jayasinghe UW; Bilinski KL; Provan PJ; Byth K; Bilous AM; Salisbury EL; Boyages J
    J Clin Pathol; 2014 Mar; 67(3):222-8. PubMed ID: 24403187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between Ki67 and breast cancer prognosis.
    Kontzoglou K; Palla V; Karaolanis G; Karaiskos I; Alexiou I; Pateras I; Konstantoudakis K; Stamatakos M
    Oncology; 2013; 84(4):219-25. PubMed ID: 23364275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
    Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
    Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
    Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki67 and proliferation in breast cancer.
    Pathmanathan N; Balleine RL
    J Clin Pathol; 2013 Jun; 66(6):512-6. PubMed ID: 23436927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer.
    Assersohn L; Salter J; Powles TJ; A'hern R; Makris A; Gregory RK; Chang J; Dowsett M
    Breast Cancer Res Treat; 2003 Nov; 82(2):113-23. PubMed ID: 14692655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer.
    Tanei T; Shimomura A; Shimazu K; Nakayama T; Kim SJ; Iwamoto T; Tamaki Y; Noguchi S
    Eur J Surg Oncol; 2011 Feb; 37(2):155-61. PubMed ID: 21111561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of Ki67 for adjuvant chemotherapy in node-negative, hormone receptor-positive breast cancer.
    Sutepvarnon A; Warnnissorn M; Srimuninnimit V
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S60-6. PubMed ID: 23590023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential utility of geminin as a predictive biomarker in breast cancer.
    Sundara Rajan S; Hanby AM; Horgan K; Thygesen HH; Speirs V
    Breast Cancer Res Treat; 2014 Jan; 143(1):91-8. PubMed ID: 24292956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis.
    Dieci MV; Barbieri E; Bettelli S; Piacentini F; Omarini C; Ficarra G; Balduzzi S; Dominici M; Conte P; Guarneri V
    J Clin Pathol; 2012 Jun; 65(6):503-6. PubMed ID: 22389512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers.
    Crosier M; Scott D; Wilson RG; Griffiths CD; May FE; Westley BR
    Clin Cancer Res; 1999 Oct; 5(10):2682-8. PubMed ID: 10537329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
    Dowsett M; Smith IE; Ebbs SR; Dixon JM; Skene A; A'Hern R; Salter J; Detre S; Hills M; Walsh G;
    J Natl Cancer Inst; 2007 Jan; 99(2):167-70. PubMed ID: 17228000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays.
    Batistatou A; Televantou D; Bobos M; Eleftheraki AG; Kouvaras E; Chrisafi S; Koukoulis GK; Malamou-Mitsi V; Fountzilas G
    Anticancer Res; 2013 May; 33(5):2139-45. PubMed ID: 23645767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.
    Zurrida S; Bagnardi V; Curigliano G; Mastropasqua MG; Orecchia R; Disalvatore D; Greco M; Cataliotti L; D'Aiuto G; Talakhadze N; Goldhirsch A; Viale G
    Eur J Cancer; 2013 Oct; 49(15):3083-92. PubMed ID: 23777741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer.
    Penault-Llorca F; André F; Sagan C; Lacroix-Triki M; Denoux Y; Verriele V; Jacquemier J; Baranzelli MC; Bibeau F; Antoine M; Lagarde N; Martin AL; Asselain B; Roché H
    J Clin Oncol; 2009 Jun; 27(17):2809-15. PubMed ID: 19380452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
    Faratian D; Munro A; Twelves C; Bartlett JM
    Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact.
    Ibrahim T; Farolfi A; Scarpi E; Mercatali L; Medri L; Ricci M; Nanni O; Serra L; Amadori D
    Oncology; 2013; 84(3):150-7. PubMed ID: 23257904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?
    Lin CH; Lu YS; Huang CS; Kuo KT; Wang CC; You SL; Lin PH; Chang DY; Kuo WH; Chang KJ; Cheng AL
    J Clin Pathol; 2011 Sep; 64(9):781-7. PubMed ID: 21642658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological work up of the primary tumor: getting the proper information out of it.
    Viale G
    Breast; 2011 Oct; 20 Suppl 3():S82-6. PubMed ID: 22015299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.